- 75 - 100 out of 18,484 results
- Status, start date (descending)
Study of the Epidemiology of Atopic Dermatitis using Natural Language Processing Algorithms in Electronic Health Records
10/30/18 → 10/30/21
Project: Research project
Prot #BST002: A Phase 2b, Open-Label, Single Arm, Multi-Center Study to Assess the Efficacy and Safety of BST-236 as a Single Agent in Adults with Newly-Diagnosed Acute Myeloid Leukemia, Not Eligible for Standard Induction Therapy
PRA Health Sciences, BioSight Ltd.
10/29/18 → 10/29/21
Project: Research project
Prot #PTI-428-06: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of PTI-428 in Subjects with Cystic Fibrosis
MS Clinical Services, LLC, Proteostasis Therapeutics, Inc.
10/29/18 → 10/29/21
Project: Research project
Interaction of the microbiome with astrocytes and amyloid pathology
Sadleir, K. R. & Vassar, R. J.
10/25/18 → 12/31/21
Project: Research project
Prot #19774: A multicenter Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of the combination of rogaratinib and copanlisib in patients with FGFR-positive, local
Bayer HealthCare Pharmaceuticals, Inc.
10/18/18 → 5/19/21
Project: Research project
Liquid Argon Bubble Chamber Support
Fermi Research Alliance, LLC, Fermi National Accelerator Laboratory, Department of Energy
10/15/18 → 11/15/19
Project: Research project
Health at a Living Wage: Evidence from Natural Experiments
University of Wisconsin-Milwaukee, Robert Wood Johnson Foundation
10/15/18 → 10/14/20
Project: Research project
Prot #UMCC 2017.026NU UM17I01: A Multi-Center Randomized Phase II Study of Nivolumab in Combination with Gemcitabine/Cisplatin or Ipilimumab as First Line Therapy for Patients with Advanced Unresectable Biliary Tract Cancer
University of Michigan, Bristol-Myers Squibb Company
10/12/18 → 7/24/27
Project: Research project
LEGACY: Local RadioEmbolization for the Assessment of Tumor Control with Yttrium-90 Glass Microspheres (TheraSphere®)
10/11/18 → 10/11/21
Project: Research project
Prot #0610-02: A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients with Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 with and without Ruxolitinib in Patients wi
Parexel, Constellation Pharmaceuticals, Inc.
10/2/18 → 10/2/21
Project: Research project
Coleman 4R Patient Care Sequences for Cancer and Supportive Care
10/1/18 → 9/30/21
Project: Research project